buthionine sulfoximine glutathione synthesis inhibitor Depletion of cellular GSH by treatment with l glutathione synthesis inhibitor Combined inhibition

glutathione synthesis inhibitor Combined inhibition of de novo and nucleotide biosynthesis is synthetically lethal in glioblastoma Buthionine sulfoximine, an inhibitor of The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma Blood Cancer Journal Frontiers Systemic L Buthionine S R Sulfoximine Treatment Increases Plasma NGF and Upregulates L cys L cys2 Transporter and Glutamylcysteine Ligase mRNAs Through the NGF TrkA Akt Nrf2 Pathway in the Striatum Full article: Redox enzyme networks shaping cancer drug metabolism and therapeutic resistance

SKU: 44412934484 · From iglepidom.org